PDCD1 and hepatocellular carcinoma: There was also a strong relationship between these eight genes, especially CD3E, ITK and TRAF3IP3, and the immune checkpoint gene PDCD1, which suggests HCC patients showing high expression of CD3E, ITK and TRAF3IP3 may respond well to immunotherapy.